Critical appraisal of lurasidone in the management of schizophrenia
Silvio Caccia, Luca Pasina, Alessandro NobiliIstituto di Ricerche Farmacologiche, “Mario Negri”, Milan, ItalyAbstract: Lurasidone is a new atypical antipsychotic in the benzoisothiazoles class of chemicals. Like most second-generation antipsychotics it is a full antagonis...
Saved in:
Main Authors: | Caccia S, Pasina L, Nobili A |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2012
|
Subjects: | |
Online Access: | https://doaj.org/article/96d715a4b74646e18bf4a8fb4ce307f5 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The clinical utility of lurasidone in schizophrenia: patient considerations
by: Harvey PD
Published: (2015) -
Lurasidone as a potential therapy for bipolar disorder
by: Woo YS, et al.
Published: (2013) -
Lurasidone for the treatment of bipolar depression: an evidence-based review
by: Franklin R, et al.
Published: (2015) -
New and extended-action treatments in the management of ADHD: a critical appraisal of lisdexamfetamine in adults and children
by: Diana Domnitei, et al.
Published: (2010) -
Critical appraisal of the role of fingolimod in the treatment of multiple sclerosis
by: Warnke C, et al.
Published: (2011)